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Abstract
Despite recent advances in our ability to genetically manipulate Rickettsia, little has been done to employ genetic tools to
study the expression and localization of Rickettsia virulence proteins. Using a mariner-based Himar1 transposition system,
we expressed an epitope-tagged variant of the actin polymerizing protein RickA under the control of its native promoter in
Rickettsia parkeri, allowing the detection of RickA using commercially-available antibodies. Native RickA and epitope-tagged
RickA exhibited similar levels of expression and were specifically localized to bacteria. To further facilitate protein expression
in Rickettsia, we also developed a plasmid for Rickettsia insertion and expression (pRIE), containing a variant Himar1
transposon with enhanced flexibility for gene insertion, and used it to generate R. parkeri strains expressing diverse
fluorescent proteins. Expression of epitope-tagged proteins in Rickettsia will expand our ability to assess the regulation and
function of important virulence factors.
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Introduction
Rickettsia are Gram-negative alphaproteobacteria that have an
obligate intracellular growth requirement and infect arthropod
vectors and mammalian hosts. Rickettsia species are classified into
four groups – the ancestral group (AG), typhus group (TG),
transitional group (TRG), and spotted fever group (SFG) [1,2].
The SFG consists of organisms that cause spotted fever illness,
including Rickettsia parkeri, a species that was originally consid-
ered to be nonpathogenic, but is now recognized as a causative
agent of mild or moderate disease in North and South America
[3,4].
Despite clinical and biological interest in Rickettsia, tools for their
genetic manipulation have only recently been implemented. In
particular, it is now possible to transform Rickettsia with DNA [5–
7], introduce transposons into their genomes [8,9], carry out
directed mutagenesis [10], and stably transform them with
plasmids [11]. These advances have been used to express
exogenous proteins, such as fluorescent protein variants
[6,8,9,11,12]. However, little has been done to employ these tools
to study the expression, localization and function of endogenous
Rickettsia proteins.
Because of their obligate intracellular growth niche, examining
the expression and localization of Rickettsia proteins that interface
with the host cell is crucial for understanding pathogenesis. For
SFG Rickettsia such as R. parkeri, both invasion and spread involve
an interaction with the host cell actin cytoskeleton. During
invasion, actin filament polymerization underlying the host cell
plasma membrane promotes bacterial phagocytosis [13,14].
Following escape from the phagosome, bacteria use the force
from actin polymerization on their surface to propel them
through the cytosol, a process that results in the formation of
actin comet tails [15,16]. Movement drives bacteria into
protrusions of the host cell plasma membrane, leading to escape
[17] or internalization by an adjacent cell [18]. The RickA
protein has been implicated in actin assembly by Rickettsia
[19,20]. RickA mimics the activity of host proteins called
nucleation promoting factors (NPFs) by binding to and activating
the host Arp2/3 complex, an actin nucleating and organizing
factor [19,20]. The rickA gene is present in AG, TRG and SFG
species, but is absent in TG Rickettsia [21–25]. Further elucidation
of the role of RickA and other Rickettsia proteins in infection will
require the development of tools to monitor their expression and
localization.
Here, we report the implementation of epitope tagging as a
tool for observing protein expression and localization in
Rickettsia. Using a mariner-based Himar1 transposition system [9]
in R. parkeri, we expressed a FLAG-tagged variant of RickA
under the control of its native promoter, allowing for the
detection of RickA using commercially-available antibodies. To
further facilitate protein expression in Rickettsia, we developed a
new plasmid containing a variant Himar1 transposon with
enhanced flexibility for gene insertion, and used it to generate
R. parkeri strains expressing fluorescent proteins. These tools will
facilitate future studies aimed at assessing the function of
Rickettsia virulence factors.
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Transformation of R. parkeri for fluorescent protein
expression
We sought to transform R. parkeri to express recombinant
proteins, including variants of both green and red fluorescent
protein, as well as epitope-tagged Rickettsia proteins. For transfor-
mation we first employed a previously-developed mariner-based
Himar1 transposition system that is contained on the plasmid
pMW1650 (Figure 1) [9], which is engineered to express the green
fluorescent protein variant GFPUV [26]. To demonstrate the
feasibility of transforming R. parkeri, we electroporated bacteria
with pMW1650 and selected for rifampicin-resistance. Antibiotic-
resistant strains were isolated, examined for expression of GFPUV
by fluorescence microscopy, and plaque purified. Strains were
further characterized by sequencing the site of transposon
insertion and locating the sequence in the R. parkeri genome
(GenBank accession number CP003341). Two independent strains
were isolated (Table 1), each with the transposon inserted at a
different genomic location.
To facilitate the generation of R. parkeri strains that express
different fluorescent proteins, as well as recombinant versions of
endogenous Rickettsia proteins, we developed a new variant of
plasmid pMW1650 called plasmid for Rickettsia insertion and
expression (pRIE) (Figure 1). In addition to the features in
pMW1650, pRIE contains two multiple cloning sites: MCS1 for
strong expression of genes, such as those encoding fluorescent
proteins, under the control of the R. rickettsii ompA promoter; and
MCS2 for expression of a Rickettsia gene under the control of its
native promoter or another promoter of choice. To test the utility
of pRIE, we generated versions containing genes encoding
enhanced GFP [27] (pRIE-EGFP), the red fluorescent protein
variant mCherry [28] (pRIE-mCherry), or three tandem copies of
mCherry (pRIE-3XmCherry). R. parkeri were electroporated with
each pRIE variant, antibiotic-resistant strains expressing the
fluorescent proteins were plaque purified, and the site of
transposon insertion was determined. For each, at least one
independent strain was isolated (Table 1).
When cells were infected with representative strains trans-
formed with either pMW1650 or pRIE, expression of fluorescent
proteins was readily observed (Figure 2). Thus, the pRIE
transposon system is useful for expressing diverse fluorescent
proteins either singly or as tandem fusions. Notably, all strains
formed actin comet tails in cells (Figure 2), suggesting that
transposon insertion and fluorescent protein expression does not
affect the process of actin-based motility.
FLAG-RickA expression in R. parkeri
We next sought to express a recombinant, epitope-tagged
version of the endogenous R. parkeri RickA protein, which would
enable protein detection and isolation using commercially-
available antibodies. The epitope tag we chose was the FLAG
peptide (DYKDDDDK), which is recognized by antibodies useful
for immunoblotting, immunofluorescence microscopy, and protein
purification [29]. The gene encoding FLAG-RickA under the
control of the native RickA promoter was subcloned into the PstI
and BsaAI sites in pMW1650, between the GFP gene and the
ColE1 origin of replication (Figure 1), generating pMW1650-
FLAG-RickA. The plasmid was then introduced into bacteria by
electroporation, followed by antibiotic selection, visual screening
for GFPUV expression, and plaque purification. Three indepen-
dent strains were isolated, each with the transposon in a different
genomic location (Table 1).
The expression of FLAG-RickA, endogenous RickA, and GFP,
was assessed in untransformed bacteria, in strains transformed
with the parent plasmid pMW1650, or strains transformed with
pMW1650-FLAG-RickA (Figure 3). All strains expressed endog-
enous RickA at similar levels, as assessed by immunoblotting using
anti-RickA antibodies [20]. All transformed strains expressed
Figure 1. Physical maps for pMW1650 and pRIE. Both pMW1650 [9] and pRIE contain a Himar1 transposase gene under the control of the
Borrelia burgdorferi flgB promoter, and a kanamycin resistance gene (KanR). Within the transposable element, bounded by inverted repeats (IR), are an
E. coli ColE1 origin of replication, a GFPUV gene under the control of the R. rickettsii ompA promoter, and a rifampicin resistance gene (RifR) under the
control of the rpsL promoter. In addition, pRIE contains two multiple cloning sites: MCS1 for insertion of fluorescent protein genes under the control
of the R. rickettsii ompA promoter, and MCS2 for insertion of other genes to be expressed under the control of their native promoter.
doi:10.1371/journal.pone.0037310.g001
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FLAG-RickA also expressed FLAG-RickA, as detected by
immunoblotting with anti-FLAG antibody. FLAG-RickA could
be separated from native RickA by SDS-PAGE because of its
slightly larger molecular mass, and was expressed at levels similar
to those of native RickA as detected using anti-RickA antibodies.
Thus, epitope-tagged Rickettsia proteins can be expressed from
their native promoters at endogenous levels, and can be readily
detected by immunoblotting using commercially-available anti-
bodies.
Given that RickA has been proposed to function in actin-based
motility [19,20], we examined whether expression of FLAG-RickA
affects this process. The association of bacteria with actin and the
rates of movement were compared for representative strains
transformed with pMW1650 (GFP-2) or pMW1650-FLAG-RickA
(FLAG-RickA-2) (Figure 4). Both strains formed actin comet tails
and moved at mean rates that were statistically indistinguishable
from untransformed control bacteria (motility rates mean +/2
standard deviation: control, 9.8+/21.8 mm/min; GFP-2, 9.7+/
21.7 mm/min; FLAG-RickA-2, 9.2+/21.5 mm/min). Thus the
expression of FLAG-RickA did not affect actin-based motility.
To assess whether FLAG-RickA can serve as a marker for
RickA in R. parkeri cells, we assessed the presence of RickA by
immunofluorescence microscopy (Figure 5). RickA could be
detected associated with the majority of R. parkeri using anti-
RickA antibodies. Similarly, FLAG-RickA was detected in FLAG-
RickA-expressing bacteria using anti-FLAG antibody, but was not
detected in untransformed bacteria. RickA and FLAG-RickA were
detected in most but not all bacteria, suggesting that there are
differences in RickA expression or antibody accessibility in
individual bacteria within the population. These results indicate
that FLAG-RickA can be used as a marker for endogenous RickA
in bacterial cells.
Discussion
Our results indicate that epitope-tagged proteins such as FLAG-
RickA can be expressed at similar levels to their endogenous
counterparts in Rickettsia and can thus be used as markers for
protein expression and localization. RickA has been implicated in
actin-based motility [19,20,30] and suggested to be a factor that
might promote actin assembly during invasion of host cells [31]. In
previous studies, RickA has been reported to be localized on the
bacterial surface by immunofluorescence microscopy [19,32], and
in association with the inner and outer membranes as well as in the
extracellular space by immunoelectron microscopy [32]. In our
experiments, both FLAG-RickA and endogenous RickA were
detected in association with bacteria in a pattern consistent with
these previous findings. Interestingly, we detected FLAG-RickA
and RickA associated with most but not all bacteria, suggesting
that RickA expression may vary during Rickettsia infection or the
bacterial cell cycle. The use of epitope-tagged variants of RickA
should facilitate future studies aimed at further examining its
expression, biochemical interactions, localization and function
during infection.
To facilitate the expression of epitope-tagged proteins in
Rickettsia, we developed an improved variant of plasmid
pMW1650 [9], called pRIE, which harbors a Himar1 transposon
with enhanced flexibility for gene insertion. The transposon in
pRIE contains two multiple cloning sites, one for insertion of genes
encoding a fluorescent protein of choice under the control of the
R. rickettsii ompA promoter, and the other for insertion of any gene
encoding an epitope-tagged or untagged protein under the control
of its native promoter or another promoter of choice. Because the
transposon integrates into the genome in a single copy, it offers the
advantage of expressing an epitope-tagged protein at similar levels
to its endogenous counterpart. This contrasts with recently
developed Rickettsia shuttle plasmids, which are present in higher
copy number in transformed bacteria [11], and are thus likely to
overexpress proteins. A potential disadvantage of the transposon-
based system, however, is that introducing transposons into the
Rickettsia genome often disrupts genes, and in our experiments all
but one of the insertion sites were in predicted coding sequences.
Nevertheless, we did not observe any phenotypic consequences of
transposon insertion on bacterial growth or actin-based motility.
Moreover, transposon insertion has been used to complement
mutations in R. rickettsii [33], suggesting that genes expressed from
transposons can maintain their normal regulation and function.
Thus, transposon insertion is a viable method for expressing
proteins in Rickettsia, and the design of pRIE will facilitate
expression of multiple genes from separate promoters for protein
localization and genetic complementation experiments.
Transformation of Rickettsia with transposons that express
epitope-tagged and fluorescent proteins can be added to a growing
list of genetic manipulations that have recently been implemented,
which also include directed mutagenesis [10] and stable transfor-
mation with plasmids [11]. Taken together, these advances will
expand our ability to define the factors important for Rickettsia
virulence and characterize the mechanisms through which they
impact the host cell.
Table 1. Transposon insertion sites for R. parkeri strains.
Strain Insertion site Insertion site gene
pMW1650-1 752,507–752,510 between MC1_40245 and MC1_40250
pMW1650-2 14,101–14,104 between MC1_t07582 and MC1_00100
pMW1650-FLAG-RickA-1 663,623–663,626 In MC1_03780
pMW1650-FLAG-RickA-2 612,772–612,775 In MC1_03530
pMW1650-FLAG-RickA-3 772,629–772,632 In MC1_04385
pRIE-EGFP-1 210,826–210,827 In MC1_01110
pRIE-mCherry-1 220,664–220,700 In MC1_01155
pRIE-3XmCherry-1 1,203,629–1,203,630 In MC1_07005
pRIE-3XmCherry-2 1,237,065–1,237,066 In MC1_07155
doi:10.1371/journal.pone.0037310.t001
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Plasmids
pMW1650 (Figure 1) was a gift from D. Wood (University of
South Alabama, Mobile). To generate pMW1650-FLAG-RickA,
the upstream 300 bp of genomic sequence was amplified from
boiled R. parkeri by PCR using primers 59-CCGCACGTA-
CATCCGTAATTTTACAGGTATATTAC-39 and 59-CCTT-
TATCATCATCATCTTTATAATCCATGCCATATACCTAC-
TATAAATTAATATCAG-39, which included a sequence encod-
ing part of the FLAG tag. The coding sequence for RickA was
amplified using primers 59- GGATTATAAAGATGATGATGA-
TAAAGGTACCGCGGGTATGGTTAAAGAAATAGATATA-
AATAAATTATTAG-39 and 59-CATTTAACTAGTTTATC-
TAACAAATGATGGTTTTTGTG-39, which also included a
sequence encoding part of the FLAG tag. These PCR products
were combined and a fusion gene was generated by PCR using
primers 59-CCGCACGTACATCCGTAATTTTACAGGTAT-
ATTAC-39 and 59-CGCCTGCAGTAATTTCTTTGGTAAAA-
GAATAGTTGAAATAACTAAGAAGTTTAAAGGGTAGATT-
TATATGGTGTTTTATGTCATTCCCACTTCCGTGGGAAT-
GACATTTAACTAGTTTATCTAACAAATGATGGTTTTTG-
39, which also incorporate the RickA 39 untranslated region. The
resulting PCR product was subcloned into the BsaAI and PstI sites
in pMW1650.
pRIE (Figure 1) and Rickettsia codon-optimized mCherry were
synthesized by Genscript. The sequence of pRIE is available in
GenBank (accession number JQ638951). Rickettsia codon-opti-
mized EGFP was synthesized by Integrated DNA Technologies.
To generate pRIE-mCherry and pRIE-EGFP, the mCherry and
EGFP genes were subcloned into the HindIII and XbaI sites in
pRIE. To generate pRIE-3XmCherry, the mCherry gene was
amplified by PCR to generate intervening linkers containing XhoI
(between copies 1 and 2) or BglII sites (between copies 2 and 3),
and then ligated into pRIE using HindIII and XbaI. All plasmid
sequences were confirmed by DNA sequencing at the University of
California, Berkeley, sequencing facility.
Figure 2. Expression of fluorescent proteins in R. parkeri. R.
parkeri strains expressing (A) GFPUV, (B) EGFP, (C) mCherry, and (D)
3XmCherry are shown in infected Cos7 cells alone (left) and together
with actin filaments (right). Colors are indicated in the image. Scale bar
10 mm.
doi:10.1371/journal.pone.0037310.g002
Figure 3. Expression of FLAG-RickA in R. parkeri. Immunoblots of
R. parkeri strains that are not transformed (untransformed), transformed
with pMW1650 to express GFPUV (GFP-1, 2), and transformed with
pMW1650-FLAG-RickA to express GFPUV and FLAG-RickA (FLAG-RickA-1,
2, 3), probed with anti-RickA (top blot; higher molecular mass band is
FLAG-RickA, lower is endogenous RickA), anti-FLAG (middle blot) or
anti-GFP antibodies (bottom blot). Equal volumes were loaded into
each lane, and the levels of endogenous RickA serve as a built in
loading control.
doi:10.1371/journal.pone.0037310.g003
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The R. parkeri Portsmouth strain was a gift from C. Paddock
(Centers for Disease Control and Prevention, Atlanta). R. parkeri
was propagated in Vero African green monkey epithelial cells
(from ATCC, via the University of California, Berkeley, tissue
culture facility) grown at 33uC with 5% CO2, and purified by
Renografin density gradient centrifugation as described previously
[34]. R. parkeri clonal strains expressing GFPUV, GFPUV and
FLAG-RickA, EGFP, mCherry, or 3XmCherry were generated
by electroporating freshly-prepared bacteria suspended in 100 ml
250 mM sucrose with 20–25 mg of plasmid DNA (pMW1650,
pMW1650-FLAG-RickA, pRIE-EGFP, pRIE-mCherry, or pRIE-
3XmCherry, respectively) at 2.5 kV, 200 ohms, 25 mF, for 5 ms
using a Gene Pulser Xcell (Bio-Rad). Bacterial viability decreased
an average of 4-fold following electroporation, as detected by
counting plaque-forming units before and after electroporation.
Electroporated bacteria were resuspended in 500–1000 ml brain
heart infusion (BHI) media (Difco), and used to infect Vero cells to
perform polyclonal purification or direct plaque purification.
For polyclonal purification, 500 ml of electroporated bacteria
were used to infect 25–75 cm
2 flasks of Vero cells. Cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM) with 2%
fetal bovine serum (FBS) overnight at 33uC with 5% CO2, and
after 18–24 h media was replaced with media containing 200 ng/
ml rifampicin (Sigma-Aldrich). After 5–7 d, plaques were visible in
the cell monolayer. The resulting polyclonal stock was collected,
amplified and plaque purified as described below to yield a clonal
strain. For direct plaque purification, 100 ml electroporated
bacteria was used to infect each well of a 6-well plate of Vero
cells and immediately overlaid with 3 ml of DMEM with 5% FBS
and 0.5% agarose. Approximately 20 h post infection, 2 ml of
DMEM with 5% FBS, 500 ng/ml rifampicin and 0.5% agarose
was overlaid on each well. After 4–6 d, plaques were isolated and
resuspended in 200 ml of BHI before being used to infect a 25 cm
2
flask of Vero cells. Strains propagated in this way were collected,
and plaque purified a second time before mapping of the
transposon insertions sites.
The insertion site of each pMW1650-derived transposon
cassette was determined as described previously [9]. Briefly,
genomic DNA from R. parkeri was digested with HindIII, the
restriction enzyme was heat-inactivated, and the DNA fragments
were self-ligated. E. coli were transformed with the resulting
plasmids, and selected for resistance to 100 mg/ml rifampicin. The
insertion sites were sequenced using transposon-specific primers
59-CGCCACCTCTGACTTGAGCGTCG-39 and 59-CCATAT-
GAAAACACTCCAAAAAAC-39, and found to be positions of
Figure 4. Expression of FLAG-RickA does not affect actin-based motility. R. parkeri strains (green) transformed with (A) pMW1650 to express
GFPUV, or (B) pMW1650-FLAG-RickA to express GFPUV and FLAG-RickA, were imaged in live Cos7 cells expressing the actin marker mCherry-Lifeact
(red). Scale bar 10 mm. (C) Scatter plots of the rates of actin-based motility for untransformed bacteria (control) or strains expressing GFPUV or GFPUV
and FLAG-RickA.
doi:10.1371/journal.pone.0037310.g004
Figure 5. Detection of FLAG-RickA in bacteria. R. parkeri strains
that were not transformed (Rp) or transformed with pMW1650-FLAG-
RickA (Rp FLAG-RickA) were used to infect Vero cells and then (A)
labeled by immunofluorescence with anti-RickA antibody and stained
for DNA with DAPI, or (B) labeled by immunofluorescence with anti-
FLAG antibody and stained for DNA with DAPI. In the merged images,
RickA or FLAG are labeled in green, and DNA in red. Scale bar 10 mm.
Higher magnification images of individual bacteria (highlighted in
boxes in the lower magnification images) are shown on the right.
doi:10.1371/journal.pone.0037310.g005
Protein Expression in Rickettsia parkeri
PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e37310the R. rickettsii Sheila Smith strain [35] listed in Table 1. The
insertion site of the pRIE-derived transposon cassette was
determined using semi-random, nested PCR. The first round of
PCR amplified Rickettsia DNA using a universal primer 59-
GCTAGCGGCCGCACTAGTCGANNNNNNNNNNCTTCT-
39 (N is any nucleotide) and transposon-specific primers 59-
CACCAATTGCTAAATTAGCTTTAGTTCC-39 and 59-GTG-
AGCTATGAGAAAGCGCCACGC-39. The second PCR reac-
tion amplified products from the first round PCR products using
internal, transposon-specific primers 59-GCTAGCGGCC-
GCGGTCCTTGTACTTGTTTATAATTATCATGAG-39 and
59-GCTAGCGGCCGCCCTGGTATCTTTATAGTCCTGTC-
GG-39 and a primer 59-GCTAGCGGCCGCACTAGTCGA-39
that bound to a portion of the universal primer. PCR products
were sequenced, and transposons were found to be positions of the
R. rickettsii Sheila Smith strain [35] listed in Table 1.
Cell growth, transfection, and bacterial infection
Cos7 African green monkey kidney fibroblast cells (from
Regeneron Pharmaceuticals Inc., via the University of California,
Berkeley, tissue culture facility) and Vero cells were grown at 37uC
with 5% CO2 in DMEM (Invitrogen) with 2–10% FBS (JR
Scientific). For expression of Lifeact-mCherry [36] or Lifeact-GFP
[31] from plasmid pEGFP-N1, 150 ng of plasmid DNA was
transiently transfected into cells using Lipofectamine 2000
(Invitrogen), according to the manufacturer’s instructions. For
infections, cells were seeded onto glass coverslips in 24-well plates,
infected with R. parkeri, and incubated at 33uC with 5% CO2 for
24–48 h.
Antibodies, immunoblotting and immunofluorescence
staining
Antibodies were obtained from the following sources (in
parentheses): mouse anti-Rickettsia M14-13 and rabbit anti-
Rickettsia R4668 and I7205 (T. Hackstadt, NIH/NIAID Rocky
Mountain Laboratories; [37,38]); mouse anti-FLAG M2 mono-
clonal antibody (Sigma-Aldrich); mouse anti-FLAG M5 monoclo-
nal antibody (Sigma-Aldrich); rabbit anti-RickA [20]; rabbit anti-
GFP [39]; horseradish peroxidase conjugated anti-mouse and
rabbit secondary antibodies for immunoblotting (GE Healthcare);
Alexa 568 anti-rabbit and anti-mouse secondary antibodies for
immunofluorescence microscopy (Invitrogen Molecular Probes).
For immunoblotting, bacteria were purified from cultures with
similar levels of infection and number of bacteria per cell, purified
bacteria were lysed in protein gel sample buffer, equal volumes
were separated by SDS-PAGE, and proteins were transferred to
nitrocellulose. Membranes were blocked with 5% milk in Tris-
buffered saline (TBS), probed with primary antibodies (rabbit anti-
RickA, mouse M5 anti-FLAG, rabbit anti-GFP), followed by
HRP-conjugated secondary antibodies, and visualized with ECL
detection reagents (GE Healthcare).
For immunofluorescence microscopy of RickA, Vero cells were
fixed with 2.5% formaldehyde in phosphate-buffered saline (PBS)
at room temperature for 15 min, permeabilized in PBS with 0.5%
Triton X-100 for 5 min, and then with PBS+1 mg/ml lysozyme
(Sigma Aldrich) for 5 min. Primary antibodies were added in
PBS+2% bovine serum albumin (BSA), then secondary antibodies
were added with together with DAPI (Invitrogen Molecular
Probes) to stain DNA. For actin staining, Cos7 cells were fixed
with 4% paraformaldehyde in PBS at room temperature for
15 min, permeabilized in PBS with 0.5% Triton X-100, and actin
filaments were labeled with 4 U/ml Alexa 568- or 488-conjugated
phalloidin (Invitrogen Molecular Probes). Coverslips were mount-
ed with Prolong Gold antifade (Invitrogen Molecular Probes) and
stored at 4uC.
Imaging
Images were captured using a Nikon Eclipse Ti equipped with a
606(1.49 NA) TIRF objective and an Andor Clara Interline CCD
camera (Figure 2), an Olympus IX71 microscope equipped with a
1006 (1.35 NA) PlanApo objective lens and a Photometrics
CoolSNAP HQ camera (Figure 4), or an Applied Precision
DeltaVision 4 Spectris microscope equipped with a 606PlanApo
(1.4 NA) and a Photometrics CH350 CCD camera (Figure 5).
Standard images (Figures 2 and 4) were captured using
MetaMorph software (Molecular Devices), and then cropped
and adjusted for brightness/contrast using Adobe Photoshop or
ImageJ. Deconvolution images (Figure 5) were captured using
SoftWoRx v3.3.6 software (Applied Precision), deconvolved with
Huygens Professional v3.1.0p0 software (Scientific Volume Imag-
ing), and processed using Imaris (Bitplane) and Adobe Photoshop.
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